l e t t e r s Charged multivesicular body protein 1A (CHMP1A; also known as chromatin-modifying protein 1A) is a member of the ESCRT-III (endosomal sorting complex required for transport-III) complex 1,2 but is also suggested to localize to the nuclear matrix and regulate chromatin structure 3 . Here, we show that loss-of-function mutations in human CHMP1A cause reduced cerebellar size (pontocerebellar hypoplasia) and reduced cerebral cortical size (microcephaly). CHMP1A-mutant cells show impaired proliferation, with increased expression of INK4A, a negative regulator of stem cell proliferation. Chromatin immunoprecipitation suggests loss of the normal INK4A repression by BMI in these cells. Morpholino-based knockdown of zebrafish chmp1a resulted in brain defects resembling those seen after bmi1a and bmi1b knockdown, which were partially rescued by INK4A ortholog knockdown, further supporting links between CHMP1A and BMI1-mediated regulation of INK4A. Our results suggest that CHMP1A serves as a critical link between cytoplasmic signals and BMI1-mediated chromatin modifications that regulate proliferation of central nervous system progenitor cells.
As part of ongoing studies of human disorders affecting neural progenitor proliferation, we identified three families characterized by under development of the cerebellum, pons and cerebral cortex ( Fig. 1a-d) .
In a consanguineous pedigree of Peruvian origin, three children in two branches were affected ( Fig. 1e, family 1 ). Two additional pedi grees from Puerto Rico showed similar pontocerebellar hypoplasia and microcephaly ( Fig. 1e, families 2 and 3 ). Brain magnetic reso nance imaging (MRI) of affected individuals from all families showed severe reduction of the cerebellar vermis and hemispheres relative to normal individuals. Notably, the cerebellar folds (folia) were relatively preserved, despite the extremely small cerebellar size ( Fig. 1a-d and Supplementary Videos 1 and 2). All affected individuals had severe pontocerebellar hypoplasia, although affected individuals in family 1 showed better motor and cognitive function than those in families 2 and 3 (Supplementary Note).
Genomewide linkage analysis of families 1 and 2 using SNP micro arrays implicated only one region on chromosome 16q as linked and homozygous in all six affected individuals ( Fig. 1e and Supplementary  Fig. 1) , with a maximum multipoint logarithm of odds (LOD) score of 3.68 ( Fig. 1e) . Although families 2 and 3 are not highly informative for linkage analysis, their shared homozygosity provides additional sup port for the involvement of this locus. Furthermore, families 2 and 3 shared the same haplotype ( Supplementary Fig. 1 ), suggesting a founder effect. Sequencing of 42 genes within the candidate interval at 16q24.3 revealed homozygous variants predicted to be deleterious only in the CHMP1A gene. CHMP1A (NM_002768) consists of seven exons encoding a 196aminoacid protein (Supplementary Note). Affected individuals in families 2 and 3 had a homozygous nonsense variant in exon 3 predicted to prematurely terminate translation (c.88C>T, p.Gln30*; Fig. 2a,b) . Family 1 showed a homozygous vari ant in intron 2 of CHMP1A (c.28-13G>A; Fig. 2a,b ) predicted to cre ate an aberrant splice acceptor site leading to an 11bp insertion in the spliced mRNA product (Supplementary Fig. 2a ). The two mutations were absent from dbSNP, 281 neurologically normal European control DNA samples (562 chromosomes), the 1000 Genomes Project data base 4 and approximately 5,000 control exomes from the National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project.
l e t t e r s
We sequenced CHMP1A in 64 individuals with other cerebellar anomalies without find ing additional mutations, but none of these affected individuals shared the rare and distinctive pattern of hypo plasia seen in the individuals with CHMP1A mutations.
RTPCR analysis of CHMP1A in lymphoblastoid cells from affected individuals from family 1 (CH3101 and CH3105) identified the pre dicted aberrant transcript with the 11bp insertion and a second aberrant transcript with a 21bp insertion but no normal CHMP1A transcript ( Supplementary Fig. 2b ). In the parents of affected chil dren from family 1 and in unaffected control samples, only the normal transcript was detected, suggesting that the abnormal splice products are unstable. Protein blot analysis revealed a single 24kDa band in a normal control individual, but no corresponding band was detected in affected individuals from families 1 and 2 (CH3101 and CH2401, respectively; Fig. 2c ). In the parent (CH3103), the amount of CHMP1A was 50% relative to the amount detected in control lysate. Hence, this genetic study establishes CHMP1A null mutations as the cause of pon tocerebellar hypoplasia and microcephaly in these pedigrees.
CHMP1A has been assigned two distinct putative functions as both a chromatinmodifying protein and a charged multivesicular Multipoint LOD score Fig. 1 ).
Genes in the region of LOD of >3 are indicated to the right of the graph. npg l e t t e r s body protein 1, 3 . CHMP1A was originally identified as a binding partner of the Polycomb group protein Pcl (Polycomblike) 3 . In the nucleus, it has been suggested to recruit the Polycomb group tran scriptional repressor BMI1 to heterochromatin, and overexpressed CHMP1A has been shown to arrest cells in S phase 3 . In the cytoplasm, CHMP1A is part of the ESCRTIII complex 1,2 . The ESCRTIII com plex localizes to endosomes and interacts with VPS4A and VPS4B 5 to assist in the trafficking of ubiquitinated cargo proteins to the lyso some for degradation 6 .
We investigated the potential effects of CHMP1A on Polycomb function by analysis of cell lines from two affected individuals har boring different CHMP1A mutations (CH3101 from family 1 and CH2401 from family 2), which show severely impaired doubling times compared to control cell lines, suggesting essential roles for CHMP1A in regulating cell proliferation (Fig. 2d) . To examine BMI1 function in these cells, we performed quantitative PCR (qPCR) analysis of expression of the BMI1 target locus CDKN2A, which encodes alternative transcripts INK4A (also known as p16 INK4A ; NM_000077) and ARF (also known as p14 ARF ; NM_058195) in humans. This analysis revealed abnormally high expression of INK4A, the isoform implicated in cerebellar development, but not of ARF ( Fig. 2e ), suggesting derepression of INK4A. Chromatin immunoprecipitation (ChIP) with an antibody to BMI1 in control cell lines showed an approximately eightfold enrichment of BMI1 binding at INK4A promoter DNA relative to a control region 7 kb upstream, whereas cells from an affected individual (CH2401) showed only approximately half this enrichment in BMI1 binding (Fig. 2f) . Enrichment of BMI1 at the ARF promoter was not substan tial in this assay and was similar in both control cells and cell lines from affected individuals, consistent with the specificity of regula tion of the INK4A isoform by BMI1 (Fig. 2f) . Bmi1 has been shown to suppress the Cdkn2a locus and be required for neural stem cell selfrenewal 7 . Our evidence suggests a role for CHMP1A in mediat ing BMI1directed epigenetic silencing at the INK4A promoter but not at the ARF promoter.
We further explored the relationship between CHMP1A and BMI1 using morpholinobased knockdown experiments in zebrafish. Knockdown of the zebrafish CHMP1A ortholog (chmp1a; NM_200563) resulted in reduced cerebellum and forebrain volume compared to control, uninjected zebrafish, similar to the effects of human CHMP1A mutations and knockdown in zebrafish of BMI1 orthologs (bmi1a, NM_194366, and bmi1b, NM_001080751; Fig. 3a-e and Supplementary Figs. 3 and 4) . A second morpholino target ing chmp1a led to a similar phenotype, and both morpholinos were partially rescued by the introduction of human CHMP1A mRNA, confirming morpholino specificity (Supplementary Fig. 4) . The cerebellum consists of five major cell types, with the principal cell, known as the Purkinje cell, deriving from the ventricular epithelium, whereas granule cells derive from a separate progenitor pool known as the rhombic lip. Granule cell precursors then migrate over the outer surface of the cerebellum and form the external germinal layer (EGL) before migrating radially past the Purkinje cells to settle in the internal granule layer (IGL) 8 . Within the chmp1amorphant cerebel lum, the internal granule and molecular layers were severely affected (Fig. 3a,b) , which is consistent with the relatively preserved folia pattern of the human cerebellum (thought to primarily be established by Purkinje cells) and severely reduced volume (which is determined mainly by granule cell quantity).
We then tested genetic interactions between chmp1a and the zebrafish ortholog of INK4A (cdkn2a; XM_002660468). Knockdown of cdkn2a alone did not result in noticeable abnormalities, and double knockdown of chmp1a and cdkn2a resulted in partial rescue of the brain morphology defects seen with chmp1a knockdown (Fig. 3f,g) . This rescue was analogous to the rescue of the Bmi1knockout mouse cerebellar phenotype in Bmi1 and Cdkn2adouble knockout mice 9 . Of note, there were also parallels in brain morphology between individuals with CHMP1A mutations and Bmi1deficient mice, which show cer ebellar hypoplasia 10, 11 (Fig. 3h,i) . In Bmi1null mice, the cerebellar architecture was generally preserved, but the thickness of the granular and molecular layers was markedly reduced 10 npg l e t t e r s mice show a modest reduction in cerebral volume 10, 12 , similar to indi viduals with CHMP1A mutations (Supplementary Note) .
Subcellular localization of CHMP1A seems to vary depending on the cell type. Confocal images of NIH 3T3 cells showed prominent exclusion of Chmp1a from the nucleus (mouse Chmp1a, NM_145606), where Bmi1 was detected (Fig. 4a) . In contrast, confocal images of HEK 293T cells, although also showing predominantly cytoplasmic localization of CHMP1A, showed some nuclear immunoreactivity as well (Fig. 4b) . Primary cultures of cerebellar granule cells from mice also showed predominantly cytoplasmic localization of Chmp1a, along with a speckled nuclear pattern (Fig. 4c) . Overexpression of HAtagged mouse Chmp1a in cultured granule cells resulted in abun dant nuclear Chmp1a with a punctate expression pattern, confirming the speckled nuclear localization of endogenous Chmp1a (Fig. 4d) and consistent with earlier reports that CHMP1A can be present in the nucleus 3 . Even with Chmp1a overexpression, Chmp1a and Bmi1 do not prominently colocalize within the nucleus, which is also in agreement with previous data 3 .
Immunohistochemical studies of the developing cerebellum and cerebral cortex in mice revealed widespread expression of Chmp1a in dividing and postmitotic cells. Chmp1a immunoreactivity was seen in the nucleus and cytoplasm of EGL, Purkinje and IGL cells at post natal day (P) 2 (Fig. 4e,f and Supplementary Fig. 5 ). In the nucleus of these cells, Chmp1a immunoreactivity was seen in a speckled pattern. These speckles may be seen adjacent to Bmi1 signals, but they usually did not colocalize ( Fig. 4f and Supplementary Fig. 5) . At later stages of cerebellar development (P4, P10 and P29), Chmp1a expression persisted in Purkinje and granule cells ( Supplementary  Fig. 6 ). Embryonic day (E) 13.5 cerebral cortex showed widespread Chmp1a expression in the neuroepithelial cells (Fig. 4g) . In the postnatal cerebral cortex (at P4, P10 and P29), Chmp1a expression in postmitotic neurons of the cortical plate gradually decreased and became almost undetectable by P29 (Supplementary Fig. 6 ). These expression studies confirm that Bmi1 and Chmp1a are often expressed in the same cells. However, the absence of widespread subcellular colocalization of Bmi1 and Chmp1a suggests that the regulation of Bmi1 by Chmp1a is perhaps not mediated by direct physical interaction.
Our data implicate CHMP1A as an essential central nervous system regulator of BMI1, which in turn is a key regulator of stem cell self renewal. The dual cytoplasmic and nuclear localization of CHMP1A and its connection to the ESCRTIII complex position CHMP1A as a potentially crucial link between cytoplasmic signals and the global regulation of stem cells via the Polycomb complex. 
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Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
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